Newsroom

LONDON--(BUSINESS WIRE)--  11 March 2026 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 10 March 2026, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Stifel Nicolaus Europe Limit...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 10 March 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 10 March 2026 Number of Public Shares Purchased: 30,849...

BÆKKE, Dinamarca--(BUSINESS WIRE)--El productor danés de ingredientes FERM FOOD ha adquirido la antigua planta de fabricación de Orkla en Skovlund (Dinamarca), con efecto a partir del 1 de abril de 2026. La operación aporta nuevas instalaciones de producción que permitirán ampliar la fabricación de ingredientes vegetales fermentados destinados a la industria alimentaria, impulsada por una demanda internacional que ha crecido más rápido de lo previsto. «Nuestras instalaciones actuales se nos han...

MEUDON, France--(BUSINESS WIRE)--As air and missile threats are evolving faster than ever, from slow-moving drones to hypersonic missiles, attacks are becoming increasingly complex, saturating and unpredictable. Thales SkyDefender provides full protection against all types of air threats, from a few kilometres to several thousands of kilometres: Short-range: for protection of forces, vital assets and sensitive sites: ForceShield creates a real protection bubble against lower layer and surface t...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF 232 million in the context of the accelerated bookbuild offering (“ABO”) of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (Private Equities Department) and Auba Investment Pte. Ltd. (all together the “Selling Shareholders”) laun...

BÆKKE, Denmark--(BUSINESS WIRE)--FERM FOOD acquires Orkla’s former site and scales up: Up to 20,000 tonnes of fermented ingredients per year...

LONDON--(BUSINESS WIRE)--Munich and Hamburg have emerged as two of Europe’s strongest investment locations in the latest edition of Europe’s Most Talked About Cities, the annual visibility report from strategic communications consultancy ING. The ranking evaluates 70 European cities based on their presence across online news outlets, digital publications and social platforms — a growing indicator of international perception and a leading signal of FDI competitiveness. In a year marked by an exp...

MEUDON, France--(BUSINESS WIRE)--Alors que les menaces aériennes et balistiques évoluent plus rapidement que jamais, des drones lents aux missiles hypersoniques, les attaques deviennent de plus en plus complexes, saturantes et imprévisibles. SkyDefender permet une protection complète contre tous types de menaces aériennes, de quelques kilomètres à plusieurs milliers de kilomètres : Courte portée : pour la protection des forces, des actifs vitaux et des sites sensibles : ForceShield crée une vér...

BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more details about future product features across its global portfolio at the upcoming 19th annual Advanced Technologies and Treatments for Diabetes Conference in Barcelona, March 11-14, 2026. “There is no better global stage than ATTD to showcase how we’re...

LIESTAL, Switzerland & TOKYO--(BUSINESS WIRE)--Curatis Holding AG (SIX: CURN) and Neupharma Co., Ltd. (“Neupharma”), a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology disorders, today announce an exclusive license and development agreement for corticorelin (C-PTBE-01) in Japan. Under the terms of the agreement, Neupharma will receive exclusive rights to develop and commercialize corticorelin for the treatment of peritumoral brain edema (PTBE) in...